Name
LIPODYSTROPHY, LOCALISED
DESCRIPTION
DETAIL
CLASSIFICATION OF LIPODYSTROPHIES : A. FALILIAL OR GENETIC FORMS - CONGENITAL GENERALISED LIPODYSTROPHY ( CGL , BERARDINELLI-SEIP SYNDROME ) - FAMILIAL PARTIAL LIPODYSTROPHY - DUNNIGAN VARIETY ( FPLD ) - KOBBERLING VARIETY - MANDIBULOACRAL DYSPLASIA VARIETY - OTHER TYPES B. ACQUIRED FORMS - ACQUIRED GENERALISED LIPODYSTROPHY ( LAWRENCE SYNDROME ) - ACQUIRED PARTIAL LIPODYSTROPHY ( BARRAQUER-SIMONS SYNDROME ) - HIV-1 PROTEASE INHIBITOR-INDUCED LIPODYSTROPHY - LOCALIZES LIPODYSTROPHIES
TYPENOTES
" No specific medical treatment exists. " " Treatment of insulin lipodystrophy consists of reassuring the patient that the condition is benign, switching to purified insulin (pork or human), and having the patient inject insulin in noninvolved areas and rotate the injection sites. This regimen is effective in more than 95% of patients. Improvement begins in 2-4 weeks, and normal consistency generally is restored within 2 months. " " Treatment of underlying immunological disorders might prevent progression of the disease. Surgical Care Surgical treatment with adipofascial flaps has been successful in some cases. Consultations Dermatological, medical, and surgical consultations are appropriate. Diet No specific dietary recommendations or restriction of diet has been recommended. Activity No specific activity or restriction of activity has been proposed.
RELATED DISEASE
Not Available Disease
DISEASE
INVESTIGATION
SERUM CHOLESTEROL, SERUM TRIGLYCERIDE, URINE ROUTINE, SERUM HDL ( FEMALE ), COMPLETE BLOOD COUNT, BLOOD SUGAR ( RANDOM )